Sodium hydride → HCID 71243724, compound
Reaction equation
[H-].[Na+].[Cl:3][C:4]1[CH:5]=[C:6]([CH2:21][OH:22])[CH:7]=[CH:8][C:9]=1[O:10][C:11]1[CH:16]=[CH:15][CH:14]=[C:13]([C:17]([F:20])([F:19])[F:18])[CH:12]=1.Cl[C:24]1[CH:25]=[C:26]2[N:33](C(OC(C)(C)C)=O)[CH2:32][CH2:31][N:27]2[C:28](=[O:30])[N:29]=1>C1COCC1>[Cl:3][C:4]1[CH:5]=[C:6]([CH:7]=[CH:8][C:9]=1[O:10][C:11]1[CH:16]=[CH:15][CH:14]=[C:13]([C:17]([F:19])([F:20])[F:18])[CH:12]=1)[CH2:21][O:22][C:24]1[CH:25]=[C:26]2[NH:33][CH2:32][CH2:31][N:27]2[C:28](=[O:30])[N:29]=1Participants
5
Procedure
Prepared in a manner similar to that described for E65 using sodium hydride (13.87 mg, 0.347 mmol), (3-chloro-4-(3-(trifluoromethyl)phenoxy)phenyl)methanol in THF (8 mL) and tert-butyl 7-chloro-5-oxo-2,3-dihydroimidazo[1,2-c]pyrimidine-1(5H)-carboxylate (62.8 mg, 0.231 mmol).
Workup
- customPrepared in a manner similar to
Sources & evidence
- ORD record
- ord-d7c43dbabce94ab08a63f6209d3f71d2
- Source dataset
- uspto-grants-2015_03
- Patent number
- US08975400B2
Reaction notes
Loading…